Join the 'Voluven' group to help and get support from people like you.
Posted 30 Apr 2015 by Drugs.com
THURSDAY, April 30, 2015 – Children undergoing heart surgery do better when they get fresh whole blood from single donors instead of "component blood" from multiple donors, new research suggests. But fresh whole blood isn't typically available for pediatric heart surgery patients, said study leader Dr. David Jobes, of the Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania in Philadelphia. "We hope that our research helps to re-examine current blood storage practice and make whole blood more readily available for pediatric patients," Jobes added. The findings are published in the May issue of Annals of Thoracic Surgery. Patients given blood or blood components can experience allergic reactions or serious complications such as lung injury and infectious disease, the researchers noted. "The risk for disease transmission in pediatric ... Read more
Related support groups: Blood Transfusion, Albumin Human, Cardiothoracic Surgery, Hespan, Plasbumin, Gentran 70, Rheomacrodex, Albutein, Plasbumin-25, Hydroxyethyl Starch, Hextend, Dextran 40, Plasma-Plex, Albuminar-20, Albumin-Alpine, Hyskon, Dextran 1, Dextran-HM, Plasmatein, Kedbumin
FDA Medwatch Alert: Hydroxyethyl Starch Solutions: FDA Safety Communication - Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding
Posted 26 Jun 2013 by Drugs.com
ISSUE: FDA has analyzed recent data that indicate an increased risk of (i) mortality and renal injury requiring renal replacement therapy in critically ill adult patients, including patients with sepsis and those admitted to the ICU; and (ii) excess bleeding particularly in patients undergoing open heart surgery in association with cardiopulmonary bypass. Refer to the FDA Safety Communication for more details about the data analysis. FDA has concluded that HES solutions should not be used in critically ill adult patients, including patients with sepsis and those admitted to the ICU, and a Boxed Warning to include the risk of mortality and severe renal injury is warranted. In addition, FDA has reviewed a meta-analysis of studies conducted in patients undergoing open heart surgery in association with cardiopulmonary bypass and has determined that an additional warning about excessive ... Read more